Results 21 to 30 of about 1,034,096 (317)

Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis

open access: yesJournal of Bone Oncology, 2019
Bone metastasis of cancer can be a result from systemic blood spreading or vertebral venous plexus spreading. Systemic blood pathway induced bone metastasis can happen in any bone in the body since the spreading is considered to be random. However, it remains unknown whether there is any pattern of vertebral venous plexus related bone metastasis.
Mingyu Zhu   +16 more
openaire   +3 more sources

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

open access: yes, 2023
Despite recent advances in treatment, melanoma remains the deadliest form of skin cancer due to its highly metastatic nature. Melanomas harboring oncogenic BRAFV600E mutations combined with PTEN loss exhibit unrestrained PI3K/AKT signaling and increased ...
Philip N. Tsichlis   +4 more
core   +1 more source

Breast cancer metastasis to the stomach [PDF]

open access: yes, 2019
Aim: This study focuses on the stomach as an unusual but not rare site of metastasis of breast cancer. Methods: We performed a literature search on gastric metastasis from breast cancer searching for reviews from 2000 to 2018 and case reports from 2013
Rampini, Alessia   +15 more
core   +1 more source

[10]-gingerol is a potent inhibitor of breast cancer metastasis in vivo

open access: yes, 2021
sem informação32322222315th International Biennial Congress of the Metastasis Research ...
Tomasin, Rebeka   +8 more
core   +1 more source

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

open access: yesNature Communications, 2019
Oncogenic exosomes can circulate in the blood, but their selective removal has not been possible. Here the authors show that aptamer-functionalised mesoporous silica nanoparticles can find to a specific population of circulating exosomes and eliminate ...
Xiaodong Xie   +17 more
doaj   +1 more source

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

open access: yesJournal of Experimental & Clinical Cancer Research, 2019
Background Sorafenib is approved as a standard therapy for advanced hepatocellular carcinoma (HCC), but its clinical application is limited due to moderate therapeutic efficacy and high incidence of acquired resistance resulted from elevated levels of ...
Ning Zheng   +8 more
doaj   +1 more source

Protocol to generate murine organotypic brain cultures for drug screening and evaluation of anti-metastatic efficacy

open access: yesSTAR Protocols, 2023
Summary: Organotypic brain cultures are short-term assays that phenotypically and functionally recapitulate brain metastatic cells in vivo. Here, we present a protocol to generate murine organotypic brain cultures for drug screening.
Lucía Zhu   +4 more
doaj   +1 more source

Hypoxia and Metastasis [PDF]

open access: yesClinical Cancer Research, 2007
In this issue of Clinical Cancer Research , Rofstad et al. ([1][1]) report on the significance of chronic (diffusion-limited) and acute (fluctuating or perfusion-limited) hypoxia in D-12 and R-18 human melanoma xenografts on the development of metastatic disease.
Naz, Chaudary, Richard P, Hill
openaire   +2 more sources

Pericyte-expressed Tie2 controls angiogenesis and vessel maturation

open access: yesNature Communications, 2017
The angiopoietins regulate vascular maturation, angiogenesis and lymphangiogenesis via their Tie receptors that were long believed to be endothelium-specific.
Martin Teichert   +13 more
doaj   +1 more source

Mechanisms of metastasis [PDF]

open access: yesBreast Cancer Research, 2008
Metastasis is an enormously complex process that remains to be a major problem in the management of cancer. The fact that cancer patients might develop metastasis after years or even decades from diagnosis of the primary tumor makes the metastatic process even more complex.
Hunter, Kent W   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy